Eric Easom
Founder at AN2 THERAPEUTICS, INC.
Net worth: 3 M $ as of 2024-04-29
Eric Easom active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Director/Board Member | 2019-10-31 | - |
| Chief Executive Officer | 2019-10-31 | - | |
| Founder | 2017-01-31 | - | |
| President | 2019-10-31 | - | |
| Chagas Disease Foundation | Director/Board Member | 2018-05-31 | - |
Resilient Biotics, Inc.
 Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Director/Board Member | 2019-01-31 | - |
Career history of Eric Easom
Former positions of Eric Easom
| Companies | Position | Start | End |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 2009-01-31 | 2017-05-31 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Director/Board Member | 2012-12-31 | 2013-12-31 |
| Chairman | 2008-12-31 | 2012-12-31 | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Sales & Marketing | 2007-06-30 | 2008-12-31 |
| Medimmune, Inc. | Sales & Marketing | 2006-03-31 | 2007-06-30 |
Training of Eric Easom
| Kelley School of Business | Masters Business Admin |
| University of Louisville | Undergraduate Degree |
Statistics
International
| United States | 10 |
Operational
| Director/Board Member | 4 |
| Sales & Marketing | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
| Chagas Disease Foundation | |
Resilient Biotics, Inc.
Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Commercial Services |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Stock Market
- Insiders
- Eric Easom
- Experience
